TherapeuticsMD (TXMD) Total Debt Growth (1y) (2011 - 2022)
TherapeuticsMD (TXMD) Total Debt Growth (1y) (2011 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -3.69% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 37.49% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -2.48% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 4.38% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -6.91% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 41.53% |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -49.88% |
| Jun 30, 2022 | -51.00% |
| Mar 31, 2022 | 7.35% |
| Dec 31, 2021 | -20.79% |
| Sep 30, 2021 | -21.22% |
| Jun 30, 2021 | -24.01% |
| Mar 31, 2021 | -22.37% |
| Dec 31, 2020 | 22.13% |
| Sep 30, 2020 | 21.96% |
| Jun 30, 2020 | 25.61% |
| Mar 31, 2020 | 231.19% |
| Dec 31, 2019 | 165.24% |
| Sep 30, 2019 | 165.30% |
| Jun 30, 2019 | 165.37% |
| Mar 31, 2013 | -95.48% |
| Dec 31, 2012 | 33.72% |
| Dec 31, 2011 | 1,178.17% |